Association Between Novel TARDBP Mutations and Chinese Patients with Amyotrophic Lateral Sclerosis

Hui-Ling Xiong,Jin-Yang Wang,Yi-Min Sun,Jian-Jun Wu,Yan Chen,Kai Qiao,Qiao-Juan Zheng,Gui-xian Zhao,Zhi-Ying Wu
DOI: https://doi.org/10.1186/1471-2350-11-8
2010-01-01
BMC Medical Genetics
Abstract:Background TARDBP mutations have been reported in patients with amyotrophic lateral sclerosis (ALS) in different populations except Chinese. The present aim is to investigate the association between TARDBP mutations and Chinese patients with ALS. Methods 71 SALS patients and 5 FALS families with non- SOD1 mutations were screened for TARDBP mutations via direct sequencing. Results A novel heterozygous variation, Ser292Asn (875G>A), was identified in the proband and 4 asymptomatic relatives including the children of the dead patient from a FALS family. Thus the dead patient, the proband's brother, was speculated to carry Ser292Asn though his sample was unavailable to the detection. This variation was not found in 200 unrelated control subjects. A homology search of the TDP-43 protein in different species demonstrated that it was highly conserved. Also, it was predicted to be deleterious to protein function with SIFT-calculated probabilities of 0.00. Therefore, Ser292Asn is predicted to be a pathogenic mutation. In addition, we have found two silent mutations (Gly40Gly and Ala366Ala) and one novel polymorphism (239-18t>c). Conclusions The present data have extended the spectrum of TARDBP mutations and polymorphisms, and supported the pathological role of TDP-43 in Chinese ALS patients.
What problem does this paper attempt to address?